drugset / Trial / NCT03028974
Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)
Phase 4
Completed
77 enrolled
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID) · collab
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The purpose of the study is to get a better understanding of the natural and adaptive immune response to the flu virus and to compare the immune cell responses to FDA-licensed flu vaccines in nasal mucosal cells and in blood.
Timeline
- Start
- 2014-09-17
- Primary completion
- 2017-11-20
- Completion
- 2017-11-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FluMist | Vaccine | — | Intranasal |
| Subject | Influenza Virus Vaccine | Vaccine | — | — |